Literature DB >> 4970371

Sulfadiazine-resistant group A Neisseria meningitidis.

C E Alexander, W R Sanborn, G Cherriere, W H Crocker, P E Ewald, C R Kay.   

Abstract

A meningitis epidemic due to Group A meningococci was unusual in that most of the strains isolated from patients were generally resistant to sulfadiazine. This is the first report of sulfonamide resistance in an epidemic strain of Neisseria meningitidis Group A.

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4970371     DOI： 10.1126/science.161.3845.1019

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  9 in total

1.  Prevalence of serogroups and sulfonamide resistance of meningococci from the civilian population in the United States, 1964-1970.

Authors:  G L Wiggins; D G Hollis; R Weaver
Journal:  Am J Public Health       Date:  1973-01       Impact factor: 9.308

2.  Sulphadiazine-resistant group A meningococci isolated during the 1968 meningitis epidemic in Greece.

Authors:  P Vassiliadis; A Kanellakis; J Papadakis
Journal:  J Hyg (Lond)       Date:  1969-06

3.  Meningococcal infections. 1. Prevalence of serogroups causing disease in US Army personnel in 1964-70.

Authors:  M S Artenstein; H Schneider; M D Tingley
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

4.  [Sensitivity of meningococci of serotype A to sulfonamide drugs].

Authors:  M Vandekerkove; G Causse; L Lapeyssonnie; R Faucon
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

5.  Entry of four tetracyclines into saliva and tears.

Authors:  P D Hoeprich; D M Warshauer
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

6.  Simplified method for the production of carbohydrate antigen from Neisseria meningitidis.

Authors:  E Weiss; J L Long
Journal:  Appl Microbiol       Date:  1969-11

7.  Spectra of susceptibility of Neisseria meningitidis to antimicrobial agents in vitro.

Authors:  L F Devine; C R Hagerman
Journal:  Appl Microbiol       Date:  1970-02

8.  A controlled field trial of a serogroup A meningococcal polysaccharide vaccine.

Authors:  M H Wahdan; F Rizk; A M el-Akkad; A A el-Ghoroury; R Hablas; N I Girgis; A Amer; W Boctar; J E Sippel; E C Gotschlich; R Triau; W R Sanborn; B Cvjetanović
Journal:  Bull World Health Organ       Date:  1973-06       Impact factor: 9.408

9.  Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.